IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a leading medical cannabis company operating in Israel and Germany, has announced it will release its second quarter 2023 financial results on Monday, August 14, 2023, before the market opens.

Rhea-AI Summary

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a leading medical cannabis company operating in Israel and Germany, has announced it will release its second quarter 2023 financial results on Monday, August 14, 2023, before the market opens. The company will host a zoom web conference at 9:00 a.m. ET on the same day to discuss the results and conduct a Q&A session for investors.

Interested parties can register for the zoom call using the provided link. If unable to attend live, a recording of the call will be available on the company's investor relations website within 24 hours after the event.

Argus Session date unavailable

+2.48% session move Open Argus

Details

News Market Reaction – IMCC

The recorded move for IMCC in the trading session of this news was +2.48%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TORONTO and GLIL YAM, Israel, Aug. 8, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended June 30, 2023, on Monday, August 14, 2023 before the market opens.

The Company will host a zoom web conference on the same day at 9:00a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call.

Link for the zoom call: https://us02web.zoom.us/webinar/register/WN_K_uKpL3gQ_KgdI33GaqgpA

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Company contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
+972-77-3603504
info@imcannabis.com

View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-second-quarter-2023-financial-results-on-monday-august-14-at-900am-et-301895533.html

SOURCE IM Cannabis Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will IM Cannabis (IMCC) report its Q2 2023 financial results?

IM Cannabis (IMCC) will report its second quarter 2023 financial results on Monday, August 14, 2023, before the market opens.

How can investors participate in IM Cannabis (IMCC) Q2 2023 earnings call?

Investors can participate in IM Cannabis (IMCC) Q2 2023 earnings call by registering for the zoom web conference scheduled for Monday, August 14, 2023, at 9:00 a.m. ET.

Where can I find the recording of IM Cannabis (IMCC) Q2 2023 earnings call if I miss it?

If you miss the live call, a recording of IM Cannabis (IMCC) Q2 2023 earnings call will be available on the company's investor relations website at https://investors.imcannabis.com/ within 24 hours after the call.